Inflammation and hypercoagulopathy are predominant risk factors of severity in COVID-19 patients with diabetes mellitus: Summary of a meta-analysis

Diabetes Metab Syndr. 2021 Mar-Apr;15(2):639-641. doi: 10.1016/j.dsx.2021.02.021. Epub 2021 Feb 24.
No abstract available

Keywords: COVID-19; Diabetes; Hypercoagulopathy; Inflammation; Meta-analysis.

Publication types

  • Letter
  • Comment

MeSH terms

  • COVID-19*
  • Diabetes Mellitus*
  • Humans
  • Inflammation
  • Risk Factors
  • SARS-CoV-2